Lexpos News

/Lexpos News/

GPhC issues guidance on safe service provision

The General Pharmaceutical Council (GPhC) has released advice for pharmacy owners and superintendents on safely implementing pharmacy services following the start of the Pharmacy First Service across England. This advice comes amidst persistent pressures and demands on community pharmacy services, as well as the growing suite of services offered by pharmacy teams. The GPhC has [...]

The post GPhC issues guidance on safe service provision appeared first on Community Pharmacy England.

By |February 1st, 2024|Lexpos News|Comments Off on GPhC issues guidance on safe service provision

MHRA Class 4 Medicines Defect Information: Gepretix 100mg Capsules (Exeltis UK Limited)

Class 4 Medicines Defect Information: Gepretix 100mg Capsules (Exeltis UK Limited) Drug alert number: EL (24)A/04 Date issued: 01 February 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Gepretix 100mg Capsules (Exeltis UK Limited) Company name: Exeltis UK Limited Product name: Gepretix 100mg Capsules, [...]

The post MHRA Class 4 Medicines Defect Information: Gepretix 100mg Capsules (Exeltis UK Limited) appeared first on Community Pharmacy England.

By |February 1st, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Gepretix 100mg Capsules (Exeltis UK Limited)

MHRA issues new materials for valproate safety measures

This week the MHRA has issued new safety and educational materials for patients and healthcare professionals to support the implementation of the new regulatory measures. These materials include: Updated Patient Guide Updated Healthcare Professional Guide Updated Annual Risk Acknowledgement Form New Risk Acknowledgment Form for male patients starting valproate Patient Card Pharmacy Poster Warning Stickers [...]

The post MHRA issues new materials for valproate safety measures appeared first on Community Pharmacy England.

By |February 1st, 2024|Lexpos News|Comments Off on MHRA issues new materials for valproate safety measures

Rolled over price concessions for January 2024

The following price concessions granted in January 2024 have rolled over to February 2024: Drug Pack size Price concession Baclofen 10mg tablets 84 £1.99 Benzydamine 0.15% mouthwash sugar free 300 £4.79 Carbocisteine 250mg/5ml oral solution 300 £7.49 Co-careldopa 12.5mg/50mg tablets 90 £4.26 Flucloxacillin 500mg capsules 28 £2.41 Lansoprazole 30mg gastro-resistant capsules 28 £1.30 Pregabalin 200mg [...]

The post Rolled over price concessions for January 2024 appeared first on Community Pharmacy England.

By |February 1st, 2024|Lexpos News|Comments Off on Rolled over price concessions for January 2024

January 2024 Price Concessions – Final Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (31/01/2024) announced the following final list of price concessions for January 2024: Drug Pack size Price concession Amoxicillin 250mg/5ml oral suspension 100 £2.45 Anastrozole 1mg tablets 28 £1.38 [...]

The post January 2024 Price Concessions – Final Update appeared first on Community Pharmacy England.

By |January 31st, 2024|Lexpos News|Comments Off on January 2024 Price Concessions – Final Update